Form 8 (DD) - David Ginsburg
20. Dezember 2018 07:00 ET
|
Shire plc
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2 and 8.4 of the Takeover...
Form 8 (DD) - Susan Kilsby
20. Dezember 2018 07:00 ET
|
Shire plc
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2 and 8.4 of the Takeover...
Form 8 (DD) - Sara Mathew
20. Dezember 2018 07:00 ET
|
Shire plc
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2 and 8.4 of the Takeover...
Form 8 (DD) - Steven Gillis
20. Dezember 2018 07:00 ET
|
Shire plc
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2 and 8.4 of the Takeover...
Form 8 (DD) - Gail Fosler
20. Dezember 2018 07:00 ET
|
Shire plc
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2 and 8.4 of the Takeover...
Form 8 (DD) - Olivier Bohuon
20. Dezember 2018 07:00 ET
|
Shire plc
FORM 8 (DD) PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)Rules 8.1, 8.2 and 8.4 of the Takeover...
Rule 2.9 Announcement
20. Dezember 2018 02:00 ET
|
Shire plc
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
Rule 2.9 Announcement
18. Dezember 2018 02:00 ET
|
Shire plc
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION....
FDA approves Shire’s Motegrity™ (prucalopride), the only serotonin-4 receptor agonist for adults with Chronic Idiopathic Constipation (CIC)
17. Dezember 2018 07:00 ET
|
Shire plc
Intended for U.S. Audience FDA approves Shire’s Motegrity™ (prucalopride), the only serotonin-4 receptor agonist for adults with Chronic Idiopathic Constipation (CIC) Unlike other prescription...
Director/PDMR Shareholding
14. Dezember 2018 08:00 ET
|
Shire plc
Director/PDMR Shareholding December 14, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) Notification of transactions by person discharging managerial responsibilities 1.Details of the...